Funded Tech Companies
Juno Therapeutics
Based in Seattle, Juno Therapeutics has funding from Venrock, Arch Venture Partners and private investors.
Company Overview
Company Name
Juno Therapeutics
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
307 Westlake Avenue North 300
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Company Background Information
Overview
Juno is a clinical-stage company that brings together three of the world's leading cancer centers -- Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children's Research Institute -- in unique partnership to advance a broad pipeline of breakthrough immunotherapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/19/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hans Bishop
Chief Financial Officer
Steve Harr
Chief Medical Officer
Mark Gilbert
Chief Scientific Officer
Ken Mohler
VP - General Counsel
Barney Cassidy
VP - Human Resources
Robin Andrulevich
VP - Manufacturing
Andy Walker
VP - R & D
Mark Frohlich
VP - Regulatory Affairs
Elizabeth Smith
Company Investors
- Venrock (Anthony Evnin)
- Arch Venture Partners (Robert Nelsen)
- Bezos Expeditions
- Alaska Permanent Fund (Michael Burns)
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs